Endocrine Journal
Online ISSN : 1348-4540
Print ISSN : 0918-8959
ORIGINALS
Next generation sequencing-based mutation screening of 86 patients with idiopathic short stature
Atsushi HattoriYuko Katoh-FukuiAkie NakamuraKeiko MatsubaraTsutomu KamimakiHiroyuki TanakaSumito DatekiMasanori AdachiKoji MuroyaShinobu YoshidaShinobu IdaMarie MitaniKeisuke NagasakiTsutomu OgataErina SuzukiKenichiro HataKazuhiko NakabayashiYoichi MatsubaraSatoshi NarumiToshiaki TanakaMaki Fukami
Author information
JOURNALS FREE ACCESS

2017 Volume 64 Issue 10 Pages 947-954

Details
Abstract

Although mutations in ACAN, FGFR3, NPR2, and SHOX typically lead to skeletal dysplasia, and mutations in GHRHR, GH1, GHR, STAT5B, IGF1, IGFALS, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS). Of these, SHOX abnormalities are known to account for a certain percentage of ISS cases, whereas the frequency of mutations in the other 10 genes in ISS cohorts remains unknown. Here, we performed next-generation sequencing-based mutation screening of the 10 genes in 86 unrelated Japanese ISS patients without SHOX abnormalities. We searched for rare protein-altering variants. The functional significance of the identified variants was assessed by in silico analyses. Consequently, we identified 18 heterozygous rare variants in 19 patients, including four probable damaging variants in ACAN, six pathogenicity-unknown variants in FGFR3, GHRHR, GHR, and IGFALS, and eight possible benign variants. Pathogenic variants in NPR2, GH1, and IGF1 were absent from our cohort. Unlike previously reported patients with ACAN mutations, our four patients with ACAN variants manifested non-specific short stature with age-appropriate or mildly delayed bone ages, and had parents of normal stature. These results indicate that ACAN mutations can underlie ISS without characteristic skeletal features, and that such mutations are possibly associated with de novo occurrence or low penetrance. In addition, our data imply that mutations in FGFR3, NPR2, and GH-IGF1 axis genes play only limited roles in the etiology of ISS.

Information related to the author
© The Japan Endocrine Society
Previous article Next article
feedback
Top